IV stem cell and exosome infusions are biologic therapies discussed within the field of regenerative medicine. These therapies are considered investigational for most medical conditions and are not approved by the U.S. Food and Drug Administration for the treatment of disease.

At Nouveau MedSpas, IV biologic infusions are reviewed only within the context of a comprehensive medical evaluation. The purpose of this evaluation is to determine whether discussion of biologic therapy is medically appropriate and safe based on an individual’s medical history, laboratory findings, and overall health status.

Clinical Expertise

Dr. Judith Rubin conducts comprehensive medical evaluations for individuals who inquire about IV biologic therapies. This process includes reviewing medical history, current diagnoses, medications, prior treatments, and relevant laboratory results or imaging when available.

The purpose of this evaluation is to determine whether discussion of IV biologic therapy is medically appropriate and safe. Some individuals have underlying conditions, medication interactions, or other risk factors that make biologic therapy unsuitable. When that occurs, patients are advised accordingly and alternative approaches may be discussed.

Because regenerative medicine remains an evolving field, Dr. Rubin emphasizes transparency about what is established, what is still being studied, and where uncertainty exists. Any recommendations are based on individualized medical judgment and careful consideration of each patient’s health profile.

Medical Contexts Reviewed During Evaluation

Some patients inquire about IV biologic therapies when they are experiencing complex or systemic health concerns. During consultation, our providers review the full medical picture, including existing diagnoses, laboratory findings, medications, and overall health status.

The evaluation focuses on determining whether discussion of investigational biologic therapies is appropriate. Many individuals are advised that infusion therapy is not suitable for their situation.

Eligibility depends on medical history, symptom patterns, comorbidities, and the results of recent laboratory studies.

Scientific Context

Stem cells and exosomes are biologic components involved in cellular signaling and communication. In laboratory and early clinical research, scientists study how these biologic materials interact with immune pathways, inflammatory responses, and cellular environments.

While this research continues to evolve, IV administration of these biologic materials remains investigational for most medical uses. Individual responses are unpredictable, and no specific medical outcomes should be expected.

What Happens During the Medical Consultation

The consultation includes a review of medical history, lab findings, medications, and current diagnoses. Your provider explains risks, limitations, and alternatives before determining whether an infusion protocol is medically appropriate.

If you would like to learn whether any regenerative medicine topics are appropriate to discuss in the context of your health history, the next step is to schedule a consultation with one of our medical providers.

This visit provides a personalized medical evaluation and guidance focused on safety, appropriateness, and informed decision-making.

What to Expect During the Infusion Visit

• Treatment is performed in-office
• Infusion time varies depending on the protocol
• Temporary fatigue or mild symptoms may occur
• Most patients resume normal activities afterward

Individual recovery varies.

Safety and Screening Protocols

Screening includes review of autoimmune status, metabolic conditions, cardiovascular health, immune function, and medication interactions. When therapy is not recommended, alternatives are discussed.

Authoritativeness and Transparency

Infusion therapy is offered within a medical environment with physician oversight. Dr. Rubin provides evidence-informed recommendations and clarifies where research is emerging or limited. Treatment decisions prioritize patient safety and clinical appropriateness.

These therapies are considered investigational for most conditions and are discussed within a consultation setting rather than presented as guaranteed treatments.

*Individual results may vary and are not guaranteed